Calcium, trace mineral, vitamin d and drug therapy combinations
CA 2109958 C · Owner: The Procter & Gamble Company · Inventors: Andon, Mark Benson
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Nutritional mineral supplements comprising calcium citrate malate salts of manganese, copper and zinc and a member or members selected from the group of vitamin D or its metabolites or precursors and drug therapies consisting of calcitonin editro-, nate, diphosphonated and amino-diphosphonates are disclosed. Estrogen can also be used with these supplements. These supplements, which provide at least 25 % RDA of the calcium trace minerals and vitamins, are used in addition to the normal diet. These supplements are useful for increasing bone growth and for treating age-related bone loss in humans and animals. The supplements may be in the form of solid tablets liquid unit dosage forms, or in a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 15, 1992 and granted June 10, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 15, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.